Literature DB >> 23985797

An Xp22.12 microduplication including RPS6KA3 identified in a family with variably affected intellectual and behavioral disabilities.

Ayumi Matsumoto1, Mari Kuwajima, Kunio Miyake, Karin Kojima, Naomi Nakashima, Eriko F Jimbo, Takeo Kubota, Mariko Y Momoi, Takanori Yamagata.   

Abstract

The ribosomal protein S6 kinase, 90 kb, polypeptide 3 gene (RPS6KA3) is responsible for Coffin-Lowry syndrome (CLS), which is characterized by intellectual disability (ID) and facial and bony abnormalities. This gene also affects nonsyndromic X-linked ID and nonsyndromic X-linked ID without bony abnormalities. Two families have been previously reported to have genetic microduplication including RPS6KA3. In the present study, we used array-comparative genomic hybridization (CGH) analysis with Agilent Human genome CGH 180K and detected a 584-kb microduplication spanning 19.92-20.50 Mb of Xp22.12 (including RPS6KA3) in the members of one family, including three brothers, two sisters, and their mother. The 15-year-old male proband and one of his brothers had mild ID and localization-related epilepsy, whereas his other brother presented borderline intelligence quotient (IQ) and attention-deficit-hyperactivity disorder (ADHD). One sister presented pervasive development disorder (PDD). Analysis of this family suggests that RPS6KA3 duplication is responsible for mild ID, ADHD, and localization-related epilepsy, and possibly for PDD.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23985797     DOI: 10.1038/jhg.2013.88

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  5 in total

1.  Recurrent Nonconvulsive Status Epilepticus in a Patient with Coffin-Lowry Syndrome.

Authors:  Markus Gschwind; Giovanni Foletti; Alessandra Baumer; Armand Bottani; Jan Novy
Journal:  Mol Syndromol       Date:  2015-05-19

2.  Genomewide association study for C-reactive protein in Indians replicates known associations of common variants.

Authors:  Gauri Prasad; Anil K Giri; Analabha Basu; Nikhil Tandon; Dwaipayan Bharadwaj
Journal:  J Genet       Date:  2019-03       Impact factor: 1.166

3.  Engineered microRNA-based regulatory element permits safe high-dose miniMECP2 gene therapy in Rett mice.

Authors:  Sarah E Sinnett; Emily Boyle; Christopher Lyons; Steven J Gray
Journal:  Brain       Date:  2021-11-29       Impact factor: 13.501

4.  A non-syndromic intellectual disability associated with a de novo microdeletion at 7q and 18p, microduplication at Xp, and 18q partial trisomy detected using chromosomal microarray analysis approach.

Authors:  Irene Plaza Pinto; Lysa Bernardes Minasi; Alex Silva da Cruz; Aldaires Vieira de Melo; Damiana Míriam da Cruz E Cunha; Rodrigo Roncato Pereira; Cristiano Luiz Ribeiro; Claudio Carlos da Silva; Daniela de Melo E Silva; Aparecido Divino da Cruz
Journal:  Mol Cytogenet       Date:  2014-06-27       Impact factor: 2.009

Review 5.  Perturbed proteostasis in autism spectrum disorders.

Authors:  Susana R Louros; Emily K Osterweil
Journal:  J Neurochem       Date:  2016-08-04       Impact factor: 5.372

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.